Is pramipexole a MAOI

No, pramipexole is not a monoamine oxidase inhibitor (MAOI). It is a dopamine agonist primarily used to treat Parkinson's disease and restless legs syndrome by stimulating dopamine receptors in the brain. MAOIs, on the other hand, work by inhibiting the enzyme monoamine oxidase, which breaks down neurotransmitters like serotonin and dopamine.